These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28132883)

  • 1. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
    Gerenu G; Martisova E; Ferrero H; Carracedo M; Rantamäki T; Ramirez MJ; Gil-Bea FJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):991-1001. PubMed ID: 28132883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications.
    Angelucci F; Čechová K; Průša R; Hort J
    CNS Neurosci Ther; 2019 Mar; 25(3):303-313. PubMed ID: 30403004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice.
    Rodriguez G; Eren M; Haupfear I; Viola KL; Cline EN; Miyata T; Klein WL; Vaughan DE; Dong H
    Psychopharmacology (Berl); 2023 Dec; 240(12):2641-2655. PubMed ID: 37700086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol use disorder disrupts BDNF maturation via the PAI-1 pathway which could be reversible with abstinence.
    Liu S; Xie X; Zhao D; Jin N; Hu Y; Wang W; Luo X; Li G; Yang Z
    Sci Rep; 2024 Sep; 14(1):22150. PubMed ID: 39333668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
    J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
    Castello NA; Green KN; LaFerla FM
    PLoS One; 2012; 7(8):e39566. PubMed ID: 22870188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.
    Liu RM; van Groen T; Katre A; Cao D; Kadisha I; Ballinger C; Wang L; Carroll SL; Li L
    Neurobiol Aging; 2011 Jun; 32(6):1079-89. PubMed ID: 19604604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol alleviates electroconvulsive shock-induced memory impairment by modulating proBDNF/mBDNF ratio in depressive rats.
    Zhang F; Luo J; Min S; Ren L; Qin P
    Brain Res; 2016 Jul; 1642():43-50. PubMed ID: 27017958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis.
    Braschi C; Capsoni S; Narducci R; Poli A; Sansevero G; Brandi R; Maffei L; Cattaneo A; Berardi N
    Aging Clin Exp Res; 2021 May; 33(5):1223-1238. PubMed ID: 32676979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
    Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
    Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease.
    Amidfar M; de Oliveira J; Kucharska E; Budni J; Kim YK
    Life Sci; 2020 Sep; 257():118020. PubMed ID: 32603820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.
    Park L; Zhou J; Koizumi K; Wang G; Anfray A; Ahn SJ; Seo J; Zhou P; Zhao L; Paul S; Anrather J; Iadecola C
    J Neurosci; 2020 Oct; 40(42):8160-8173. PubMed ID: 32928888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.
    Peng S; Garzon DJ; Marchese M; Klein W; Ginsberg SD; Francis BM; Mount HT; Mufson EJ; Salehi A; Fahnestock M
    J Neurosci; 2009 Jul; 29(29):9321-9. PubMed ID: 19625522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.
    Jiao SS; Shen LL; Zhu C; Bu XL; Liu YH; Liu CH; Yao XQ; Zhang LL; Zhou HD; Walker DG; Tan J; Götz J; Zhou XF; Wang YJ
    Transl Psychiatry; 2016 Oct; 6(10):e907. PubMed ID: 27701410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.